Skip to content
10-K

Annual Report

CHEMBIO DIAGNOSTICS, INC.

0001140361-23-014526

← back to feed
Filed
Mar 29, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 24, 2023 36.73M sh
Shares Diluted FY 2022 · Dec 31, 2022 32.27M sh
Shares Diluted FY 2022 · Dec 31, 2021 24.3M sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$12.69M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$30.89M
Short Term Debt FY 2022 · Dec 31, 2022 $18.58M
Short Term Debt FY 2022 · Dec 31, 2021 $1.2M
Cash And Equivalents FY 2022 · Dec 31, 2022 $18.18M
Cash And Equivalents FY 2022 · Dec 31, 2021 $28.77M
Stockholders Equity FY 2022 · Dec 31, 2022 $17.8M
Stockholders Equity FY 2022 · Dec 31, 2021 $34.26M
Stockholders Equity FY 2022 · Dec 31, 2020 $27.78M
Current Liabilities FY 2022 · Dec 31, 2022 $39.3M
Current Liabilities FY 2022 · Dec 31, 2021 $15.28M
Total Liabilities FY 2022 · Dec 31, 2022 $44.81M
Total Liabilities FY 2022 · Dec 31, 2021 $38.99M
Current Assets FY 2022 · Dec 31, 2022 $48.45M
Current Assets FY 2022 · Dec 31, 2021 $54.84M
Total Assets FY 2022 · Dec 31, 2022 $62.61M
Total Assets FY 2022 · Dec 31, 2021 $73.25M
Eps Diluted FY 2022 · Dec 31, 2022 −$0.72
Eps Diluted FY 2022 · Dec 31, 2021 −$1.40
Eps Basic FY 2022 · Dec 31, 2022 −$0.72
Eps Basic FY 2022 · Dec 31, 2021 −$1.40
Sga Expense FY 2022 · Dec 31, 2022 $24.28M
Sga Expense FY 2022 · Dec 31, 2021 $24.84M
Rd Expense FY 2022 · Dec 31, 2022 $7.07M
Rd Expense FY 2022 · Dec 31, 2021 $12.49M
Net Income FY 2022 · Dec 31, 2022 −$23.29M
Net Income FY 2022 · Dec 31, 2021 −$33.9M
Operating Income FY 2022 · Dec 31, 2022 −$23.64M
Operating Income FY 2022 · Dec 31, 2021 −$31.05M
Cost Of Revenue FY 2022 · Dec 31, 2022 $38.58M
Cost Of Revenue FY 2022 · Dec 31, 2021 $34.5M
Revenue FY 2022 · Dec 31, 2022 $49.52M
Revenue FY 2022 · Dec 31, 2021 $47.82M